All entries for: Cumblerland Pharmaceuticals

March 9, 2026

Cumblerland Pharmaceuticals

Neutral Outlook

South San Francisco, CA
51-200 employees

While we do not believe that the IRA or its effects will impact our ability to obtain patents in the near future, we cannot be certain that it will not affect our patent strategy in the long term.

Disease Area: Cardiology, Neurological Diseases, Rare Diseases, Respiratory Diseases
Drug Type: Small Molecule
Scroll to Top